Alarm as 10 HIV drugs out of stock

Health & Science
By Anyango Otieno and Graham Kajilwa | Oct 07, 2020

There is a shortage of 10 crucial HIV/Aids drugs as a result of Covid-19 pandemic, the UN has warned.

In a latest report by UNAids, at least 10 anti-retroviral therapy (ART) medication is in short supply.

They include Tenofovir, Abacavuir, Cotrimoxazole suspension, Ritonavir tablets, Nevirapine suspension (for new born), Zidovudine solution, Zidovudine/lamivudine (AZT/3TC), Lopinavir/ Ritonavir(LPV/r) 100/25 mg, and LPV/r pellets 40/10 formulation.

A model by the World Health Organisation and the Joint United Nations Programmes on HIV and Aids (UNAids) estimated a six-month disruption of antiretroviral therapy could lead to more than 500 000 additional Aids-related deaths, including from tuberculosis, in sub-Saharan Africa in 2020–2021.

Regulator, millers to hold crucial meeting to resolve cane price dispute

Counties leaders demand higher stake in tea estate sale

Firm charts green energy path with low-carbon emission engines

CA pushes for Sh88.5b nation-wide broadband

New Eco Levy threatens Kenya's green future and jobs, say experts

Kenyan forex traders face dream and reality gap, experts say

Kenya calls for reforms and more say in global lending institutions

CA: Internet disruptions to continue

Company plan to set up cement factory now thrown into limbo

Tax proposals will claw back gains in climate change fight

In Kenya, persons living with HIV have already confirmed a short supply of Cotrimoxazole, which is sold as Septrin.